Biotech companies in Scotland’s thriving bio-based manufacturing have been invited to apply for up to £1m...
Up To Date
Latest News
Swiss Memo Therapeutics AG will use CHF25m raised in a new Series C financing to complete a Phase II study...
Researchers led by Wolfgang Enard from LMU Munich have identified a microRNA-based mechanism that drives...
AstraZeneca plc has paid French cancer cell therapy developer Cellectis SA US$25m upfront and US$220m in...
Italian pharma company Alfasigma SpA has signed a letter of intent to acquire the filgotinib business from...
Raising $356m through a new Clinical Co-Development Co-Investment Fund (CCD-CIF), Carlyle-subsidiary...